| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |